BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 29943849)

  • 1. Prescription patterns of angiotensin-converting enzyme inhibitors for various indications: A UK population-based study.
    Mahmoudpour SH; Asselbergs FW; Souverein PC; de Boer A; Maitland-van der Zee AH
    Br J Clin Pharmacol; 2018 Oct; 84(10):2365-2372. PubMed ID: 29943849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating prescription of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in patients with diabetes and albuminuria.
    Chienwichai K; Chaloemwa P; Sangkaew S; Chang A
    Clin Nephrol; 2024 Jun; 101(6):277-286. PubMed ID: 38606848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of recommended medications after myocardial infarction in Austria.
    Winkelmayer WC; Bucsics AE; Schautzer A; Wieninger P; Pogantsch M;
    Eur J Epidemiol; 2008; 23(2):153-62. PubMed ID: 18064529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and Risk of Dementia in Heart Failure.
    Chitnis AS; Aparasu RR; Chen H; Kunik ME; Schulz PE; Johnson ML
    Am J Alzheimers Dis Other Demen; 2016 Aug; 31(5):395-404. PubMed ID: 26705381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of Renal Insufficiency on the Prescription of Evidence-Based Medicines in Patients With Coronary Artery Disease and Its Prognostic Significance: A Retrospective Cohort Study.
    Peng Y; Xia TL; Huang FY; Huang BT; Liu W; Chai H; Zhao ZG; Zhang C; Liao YB; Pu XB; Chen SJ; Li Q; Xu YN; Luo Y; Chen M; Huang DJ
    Medicine (Baltimore); 2016 Feb; 95(6):e2740. PubMed ID: 26871817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalent pharmacotherapy of US Fontan survivors: A study utilizing data from the MarketScan Commercial and Medicaid claims databases.
    O'Byrne ML; Faerber JA; Katcoff H; Huang J; Edelson JB; Finkelstein DM; Lemley BA; Janson CM; Avitabile CM; Glatz AC; Goldberg DJ
    Am Heart J; 2022 Jan; 243():158-166. PubMed ID: 34582777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical implications of an accurate problem list on heart failure treatment.
    Hartung DM; Hunt J; Siemienczuk J; Miller H; Touchette DR
    J Gen Intern Med; 2005 Feb; 20(2):143-7. PubMed ID: 15836547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-Converting Enzyme Inhibitors Reduce Uterine Fibroid Incidence in Hypertensive Women.
    Fischer NM; Nieuwenhuis TO; Singh B; Yenokyan G; Segars JH
    J Clin Endocrinol Metab; 2021 Jan; 106(2):e650-e659. PubMed ID: 33035320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations Between Hypertension, Angiotensin-Converting Enzyme Inhibitors, and Physical Performance in Very Old Adults: Results from the ilSIRENTE Study.
    Coelho-Junior HJ; Calvani R; Tosato M; Álvarez-Bustos A; Landi F; Picca A; Marzetti E
    J Frailty Aging; 2024; 13(2):74-81. PubMed ID: 38616362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug and optimal heart failure therapy prescribing in older general practice populations: a clinical data linkage study.
    Rushton CA; Strömberg A; Jaarsma T; Kadam UT
    BMJ Open; 2014 Jan; 4(1):e003698. PubMed ID: 24384895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACE-inhibitors: a preventive measure for bone flap resorption after autologous cranioplasty?
    Schütz A; Murek M; Stieglitz LH; Bernasconi C; Vulcu S; Beck J; Raabe A; Schucht P
    J Neurosurg; 2018 Nov; 131(5):1607-1614. PubMed ID: 30497161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis.
    Yarmolinsky J; Díez-Obrero V; Richardson TG; Pigeyre M; Sjaarda J; Paré G; Walker VM; Vincent EE; Tan VY; Obón-Santacana M; Albanes D; Hampe J; Gsur A; Hampel H; Pai RK; Jenkins M; Gallinger S; Casey G; Zheng W; Amos CI; ; ; ; Smith GD; Martin RM; Moreno V
    PLoS Med; 2022 Feb; 19(2):e1003897. PubMed ID: 35113855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive Drugs and Risk of Cancer: Between Scylla and Charybdis.
    Sanidas E; Velliou M; Papadopoulos D; Fotsali A; Iliopoulos D; Mantzourani M; Toutouzas K; Barbetseas J
    Am J Hypertens; 2020 Dec; 33(12):1049-1058. PubMed ID: 32529212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis.
    Yarmolinsky J; Bouras E; Constantinescu A; Burrows K; Bull CJ; Vincent EE; Martin RM; Dimopoulou O; Lewis SJ; Moreno V; Vujkovic M; Chang KM; Voight BF; Tsao PS; Gunter MJ; Hampe J; Pellatt AJ; Pharoah PDP; Schoen RE; Gallinger S; Jenkins MA; Pai RK; ; ; Gill D; Tsilidis KK
    Diabetologia; 2023 Aug; 66(8):1481-1500. PubMed ID: 37171501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study.
    Fang S; Yarmolinsky J; Gill D; Bull CJ; Perks CM; ; Davey Smith G; Gaunt TR; Richardson TG
    PLoS Med; 2023 Jan; 20(1):e1003988. PubMed ID: 36595504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetically proxied therapeutic prolyl-hydroxylase inhibition and cardiovascular risk.
    Harlow CE; Patel VV; Waterworth DM; Wood AR; Beaumont RN; Ruth KS; Tyrrell J; Oguro-Ando A; Chu AY; Frayling TM
    Hum Mol Genet; 2023 Jan; 32(3):496-505. PubMed ID: 36048866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evolution of mendelian randomization for investigating drug effects.
    Gill D; Burgess S
    PLoS Med; 2022 Feb; 19(2):e1003898. PubMed ID: 35113864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Genetically Proxied Inhibition of HMG-CoA Reductase and Epithelial Ovarian Cancer.
    Yarmolinsky J; Bull CJ; Vincent EE; Robinson J; Walther A; Smith GD; Lewis SJ; Relton CL; Martin RM
    JAMA; 2020 Feb; 323(7):646-655. PubMed ID: 32068819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 2 Diabetes and Chronic Kidney Disease: An Opportunity for Pharmacists to Improve Outcomes.
    Neumiller JJ; St Peter WL; Shubrook JH
    J Clin Med; 2024 Feb; 13(5):. PubMed ID: 38592214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema: A Case Report With a Review of Management Options.
    Ameer MA; Mushtaq J; Chaudhry H; Patel N; Khan SI
    Cureus; 2023 Jun; 15(6):e40320. PubMed ID: 37448396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.